Statement of Ownership (sc 13g)
June 21 2018 - 11:56AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Act of 1934
(Amendment No.
)
CRYO-CELL
INTERNATIONAL, INC.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
228895108
(CUSIP Number)
June 11, 2018
(Date of event which requires filing of this statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐
Rule 13d-1(d)
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
|
The information required on the remainder of this cover
page shall not be deemed to be filed for purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
|
|
|
|
|
|
|
1
|
|
NAME OF
REPORTING PERSONS
CU Blood, Inc.
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP
(a) ☐ (b) ☒
|
3
|
|
SEC USE ONLY
|
4
|
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Florida
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
5
|
|
SOLE VOTING POWER
465,426
|
|
6
|
|
SHARED VOTING POWER
-0-
|
|
7
|
|
SOLE DISPOSITIVE POWER
465,426
|
|
8
|
|
SHARED DISPOSITIVE POWER
-0-
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
465,426
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES ☐
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW 9
6.0%
|
12
|
|
TYPE OF REPORTING PERSON
CO
|
Item 1(a)
|
Name of Issuer:
|
Cryo-Cell International, Inc. (the
Issuer
)
Item 1(b)
|
Address of Issuers Principal Executive Offices:
|
700 Brooker Creek Blvd., Suite
1800, Oldsmar, FL 34677.
Item 2(a)
|
Name of Person Filing:
|
CU Blood, Inc. (
CU
)
Item 2(b)
|
Address or Principal Business Office or, if none, Residence:
|
1991 Summit Park Drive,
Suite 2000
Orlando, Florida 32810
CU is a Florida corporation.
Item 2(d)
|
Title of Class of Securities:
|
Common Stock, par value $0.01 per share.
The CUSIP number of the Common Stock of the Issuer is 228895108.
Item 3
|
If this statement is filed pursuant to Rule
13d-1(b),
or
13d-2(b)
or (c), check whether the person filing is a:
|
Not applicable.
|
|
|
|
|
Reporting Person
|
|
Number of Outstanding
Common Shares Beneficially
Owned
|
|
Percentage of Outstanding
Common Shares (1)
|
CU (2)
|
|
465,426
|
|
6.0%
|
(1) Percentage based upon 7,287,636 shares of $0.01 par value common stock outstanding as of
April 6, 2018, as reported by the Issuer in its Report on Form
10-Q,
filed with the Securities and Exchange Commission on April 16, 2018.
(2) CU has sole voting and dispositive power over all reported shares.
Item 5
|
Ownership of Five Percent or Less of a Class.
|
If this statement is being filed to
report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐
Item 6
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
Not applicable.
Item 8
|
Identification and Classification of Members of the Group.
|
Not applicable.
Item 9
|
Notice of Dissolution of Group.
|
Not applicable.
Not applicable.
SIGNATURES
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
Dated: June 21, 2018
|
|
|
|
CU Blood, Inc.
|
|
|
|
|
|
|
|
|
|
|
|
by:
|
|
/s/ Michael Ernst
|
|
|
|
|
|
|
|
|
Michael Ernst
Authorized
Signatory
|